Manifestation of psychiatric behaviors in a mouse model of griseofulvin-induced hepatic porphyria

Journal of Toxicological Sciences

Volumn 33, Issue 5, 2008, Pages 599-608

  Satoh, Yoko ^a   Iwadate, Reiko ^a   Watanabe, Yukino ^a,b   Kawai, Hiroshi ^a   Kudo, Naomi ^b   Kawashima, Yoichi ^b   Mitsumoto, Atsushi ^a  

^a JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Anxiety; Cholestasis; Depression; Griseofulvin; Heme; Porphyria

Indexed keywords

GRISEOFULVIN; HEME; IMIPRAMINE; PORPHYRIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DEPRESSION; HEPATIC PORPHYRIA; HEPATOMEGALY; LIVER INJURY; MALE; MOUSE; NONHUMAN;

ANIMALIA; MUS;

EID: 57349184623     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.33.599     Document Type: Article

References (39)

1. Anderson, K.E., Bloomer, J.R., Bonkovsky, H.L., Kushner, J.P., Pierach, C.A., Pimstone, N.R. and Desnick, R.J. (2005): Recommendations for the diagnosis and treatment of the acute porphyrias. Ann. Intern. Med., 142, 439-450.
2. Berenson, M.M., Welch, V. and Garcia-Marin, J.J. (1991): Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy. J. Lab. Clin. Med., 118, 89-98.
3. Billi de Catabbi, S.C., Falerti, A., Fuentes, F., San Martín de Viale, L.C. and Cochon, A.C. (2005): Hepatic arachidonic acid metabolism is disrupted after hexachlorobenzene treatment. Toxicol. Appl. Pharmacol., 204, 187-195.
4. Bonkowsky, H.L. and Schady, W. (1982): Neurologic manifestations of acute porphyria. Semin. Liver Dis., 2, 108-124.
5. Cantoni, L., Rizzardrni, M., Skorupska, M., Cagnotto, A., Codegoni, A., Pecora, N., Frigo, L., Ferrarese, C. and Mennini, T. (1992): Hepatic protoporphyria is associated with a decrease in ligand binding for the mitochondrial benzodiazepine receptors in the liver. Biochem. Pharmacol., 44, 1159-1164.
6. Choi, S.W., Han, J.H., Lim, K.T., Cho, H.M., Chung, K.W., Sun, H.S., Park, D.H., Kim, B.S. and Seo, E.J. (1991): Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin. J. Korean Med. Sci., 6, 146-156.
7. Costall, B., Hendrie, C.A., Kelly, M.E. and Naylor, R.J. (1987): Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology, 26, 195-200.
8. Davies, R., Schuurman, A., Barker, C.R., Clothier, B., Chernova, T., Higginson, F.M., Judah, D.J., Dinsdale, D., Edwards, R.E., Greaves, P., Gant, T.W. and Smith, A.G. (2005): Hepatic gene expression in protoporphyic FECH mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am. J. Pathol., 166, 1041-1053.
9. De Matteis, F. and Rimington, C. (1963): Disturbance of porphyrin metabolism caused by griseofulvin in mice. Br. J. Dermatol., 75, 91-104.
10. Downey, D.C. (1999): Porphyria and chemicals. Med. Hypotheses, 53, 166-171.
11. Fonia, O., Weizman, R., Coleman, R., Kaganovskaya, E. and Gavish, M. (1996): PK11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats. Hepatology, 24, 697-701.
12. Ged, C., Mendez, M., Robert, E., Lalarme, M., Lamrissi-Garcia, I., Costet, P., Daniel, J.Y., Dubus, P., Mazurier, F., Moreau-Gaudry, F. and de Verneuil, H. (2006): A knock-in mouse model of congenital erythropoietic porphyria. Genomics, 87, 84-92.
13. Hawkins, C.W., Bickers, D.R., Mukhtar, H. and Elmets, C.A. (1986): Cutaneous porphyrin photosensitization: Murine ear swelling as a marker of the acute response. J. Invest. Dermatol., 86, 638-642.
14. A receptor-mediated transmission in the hypothalamus: effects on reproductive function. Neuropharmacology, 52, 1439-1453.
15. Hift, R.J., Davidson, B.P., van der Hooft, C., Meissner, D.M. and Meissner, P.N. (2004): Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: Precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard. Clin. Chem., 50, 915-923.
16. Inafuku, K., Takamiyagi, A., Oshiro, M., Kinjo, T., Nakashima, Y. and Nonaka, S. (1999): Alteration of mRNA levels of d-aminolevulinic acid synthase, ferrochelatase and heme oxygenase-1 in griseofulvin induced protoporphyria mice. J. Dermatol. Sci., 19, 189-198.
17. Kalueff, A.V. and Nutt, D.J. (2007): Role of GABA in anxiety and depression. Depress. Anxiety, 24, 495-517.
18. Kamei, Y. (1989a): Recommendation method for measurement of enzyme activity in human serum. Aspartate aminotransferase. Jpn. J. Clin. Chem., 18, 226-230.
19. Kamei, Y. (1989b): Recommendation method for measurement of enzyme activity in human serum. Alanine aminotransferase. Jpn. J. Clin. Chem., 18, 250-254.
20. Kamei, Y. (1990): Recommendation method for measurement of enzyme activity in human serum. Alkaline phosphatase. Jpn. J. Clin. Chem., 19, 209-212.
21. Kochar, D.K., Pal, M., Kochar, S.K., Vyas, A., Kochar, A., Bindal, D. and Agrawal, R.P. (2007): Acute intermittent porphyria presenting with neurological emergency: Review of six cases. Neurology India, 55, 413-415.
22. Krijt, J., Pšenák, O., Vokurka, M., Chlumská, A. and Fakan, F. (2003): Experimental hepatic uroporphyria induced by the diphenyl-ether herbicide fomesafen in male DBA/2 mice. Toxicol. Appl. Pharmacol., 189, 28-38.
23. Li, F., Lim, C.K. and Peters, T.J. (1987): An h.p.l.c. assay for protoporphyrinogen oxidase activity in rat liver. Biochem. J., 243, 863-866.
24. Lindberg, R.L.P., Porcher, C., Grandchamp, B., Ledermann, B., Bucombining double acute accentrki, K., Brandner, S., Aguzzi, A. and Meyer, U.A. (1996): Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat. Genet., 12, 195-199.
25. Litman, D.A. and Correia, M.A. (1983): L-Tryptophan: A common denominator of biochemical and neurological events of acute hepatic porphyria? Science, 222, 1031-1033.
26. May, B.K., Ramana Bhasker, C., Bawden, M.J. and Cox, T.C. (1990): Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis. Mol. Biol. Med., 7, 405-421.
27. Millward, L.M., Kelly, P., King, A. and Peters, T.J. (2005): Anxiety and depression in the acute porphyrias. J. Inherit. Metab. Dis., 28, 1099-1107.
28. Omura, T. and Sato, R. (1964): The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378.
29. Ostapowicz, G., Fontana, R.J., Schiødt, F.V., Larson, A., Davern, T.J., Han, S.H., McCashland, T.M., Shakil, A.O., Hay, J.E., Hynan, L., Crippin, J.S., Blei, A.T., Samuel, G., Reisch, J. and Lee, W.M. (2002): Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med., 137, 947-954.
30. Papadopoulos, V., Baraldi, M., Guilarte, T.R., Knudsen, T.B., Lacapère, J.-J., Lindemann, P., Norenberg, M.D., Nutt, D,. Weizman, A., Zhang, M.-R. and Gavish, M. (2006): Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci., 27, 402-409.
31. Phillips, J.D., Jackson, L.K., Bunting, M., Franklin, M.R., Thomas, K.R., Levy, J.E., Andrews, N.C. and Kushner, J.P. (2001): A mouse model of familial porphyria cutanea tarda. PNAS, 98, 259-264.
32. Porsolt, R.D., Anton, G., Blavet, N. and Jalfre, M. (1978): Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47, 379-391.
33. Ren, S. and Correia, A. (2000): Heme: A regulator of rat hepatic tryptophan 2,3-dioxygenase? Arch. Biochem. Biophys., 377, 195-203.
34. Ruscito, B.J. and Harrison, N.L. (2003): Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy. Blood, 102, 1525-1528.
35. Sekiguchi, M. (1995): Recommendation method for measurement of enzyme activity in human serum. γ-Glutamyltranspeptidase. Jpn. J. Clin. Chem., 24, 106-121.
36. Seth, A.K., Badminton, M.N., Mirza, D., Russell, S. and Elias, E. (2007): Liver transplantation for porphyria: Who, when, and how? Liver Transpl., 13, 1219-1227.
37. A receptors triggers anxiety at puberty. Nat. Neurosci., 10, 469-477.
38. Thunell, S. (2006): Genomic approach to acute porphyria. Physiol. Res., 55, S43-S66.
39. Verma, A., Nye, J.S. and Snyder, S.H. (1987): Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. PNAS, 84, 2256-2260.